Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ?

@article{Fraile2006IsIP,
  title={Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ?},
  author={Manuel Fraile and Josep Maria Gubern and Miquel Rull and Francisco J Juli{\'a}n and Cristina Serra and Mariona Llatj{\'o}s and Pere Culell and Pere Puig and Montse Sol{\`a} and Virginia Vallejos and Antonio Mariscal and Joan Janer and Pere Deulofeu and Ferr{\`a}n Fust{\'e}},
  journal={Nuclear medicine communications},
  year={2006},
  volume={27 10},
  pages={785-9}
}
BACKGROUND The indication for sentinel node biopsy (SNB) has not been fully established yet for patients with ductal carcinoma in situ (DCIS). AIM To relate the conversion rate to invasive carcinoma with sentinel node positivity in high risk DCIS, and to refine the clinical presentation analysis in order to better select patients for SNB. For this purpose, a risk score was devised. METHODS From 1998 to 2005, 151 high-risk DCIS patients from six clinical centres were included in a… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.